In Lilly's TOGETHER trials, people on the combo lost 16.5 to 18.5 kg by week 36 versus 1.1 kg on Taltz alone, with lower blood pressure too.
Recap by typeshit. Full story at Healio.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
The group says peptides show promise but lack clinical validation, and lays out points patients should weigh first.
Loading…